Daesung Microbiological Labs revises foot-and-mouth vaccine supply contract to KRW 1.62 billion
The company corrected its procurement contract disclosure as the term ended 2026-09-30, setting the final executed value at KRW 1.62 billion versus previously disclosed KRW 3.98 billion.